Imagene AI Company
Imagene provides AI-based molecular testing for cancer, detecting in real-time, a broad range of cancerous biomarkers from the biopsy image
Technology:
Imaging
Industry:
AI, Clinical Development
Headquarters:
Tel Aviv, Tel Aviv, Israel
Founded Date:
2020-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
21500000
Last Funding Date:
2022-05-02
Last Funding Type:
Series A
Register and Claim Ownership